Comparing Lantus vs Novolog
| Lantus (insulin glargine) | Novolog (insulin aspart) |
|
|---|
| Lantus (insulin glargine) | Novolog (insulin aspart) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Lantus is a long-acting insulin that only needs to be injected once a day, subcutaneously. It is available as a prefilled pen (Lantus Solostar) or a 10mL vial. Hypoglycemia is the most common side... View more |
Prescription only
Prescribed for Type 2 Diabetes, Diabetes - Type 1, Diabetic Ketoacidosis, Nonketotic Hyperosmolar Syndrome. Novolog may also be used for purposes not listed in this medication guide. |
Related suggestions Type 2 Diabetes
Diabetes, Type 1
Popular comparisons
|
|||||||||||||||
| More about Lantus (insulin glargine) | More about Novolog (insulin aspart) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Lantus has an average rating of 6.5 out of 10 from a total of 41 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 29% reported a negative effect. |
Novolog has an average rating of 5.5 out of 10 from a total of 32 ratings on Drugs.com. 31% of reviewers reported a positive effect, while 34% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Lantus side effects |
View all Novolog side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Lantus prices |
View all Novolog prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other insulin glargine brands include: Basaglar, Lantus SoloStar, Rezvoglar, Semglee, Toujeo Max SoloStar, Toujeo SoloStar | Other insulin aspart brands include: Fiasp, Kirsty, Merilog, Merilog SoloStar, NovoLog FlexPen, NovoLog PenFill, ReliOn NovoLog | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
24 hours |
1.5 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 395 drugs are known to interact with Lantus:
|
A total of 395 drugs are known to interact with Novolog:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
April 20, 2000 |
June 07, 2000 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.